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INTRODUCTION
The genus Sagittaria (Alismataceae) comprises 25 species of herbaceous aquatic plants that are distributed throughout the Americas in tropical regions. No evidence has been found for the use of Sagittaria montevidensis ssp montevidensis in traditional medicine. However, others Sagittaria species are known to produce antibacterial compounds such as clerodane, pimarane, labdane and rosane-type diterpenoids.
1,2 During of our survey of the active substances from Alistamaceae species, [3] [4] [5] [6] fractions of different polarity deriving from the crude methanolic extract of S. montevidensis ssp montevidensis were tested against a representative set of fungi and bacteria strains. Chromatographic treatment of the most active fraction led to the isolation of a new diterpenoid abietatriene derivative, 3β,7α-dihydroxi-abieta-8,11,13-triene (1), along with a known diterpenoid, 3β-hydroxy-abieta-8,11,13-trien-7-one (2) . The structures of the compounds were determined by spectroscopic analysis including EIMS, IR, and 1D and 2D 1 H, 13 C NMR data and also by comparison of its NMR data with those of related compounds.
EXPERIMENTAL

General experimental procedures
1D and 2D
1 H, 13 C NMR spectra were acquired on a Varian Mercury plus BB spectrometer, operating at 300.059 MHz ( 1 H) and 75.458 MHz ( 13 C) for a CDCl 3 solution using TMS as an internal standard. Mass spectrometry was performed on a Shimadzu GC-MS QP 2000A, 70 eV.
Plant material
The plant material was collected in Curitiba, Paraná, Brazil and authenticated by Dr. M. do C. Amaral (IB-UNICAMP). A voucher specimen (# UEC 115194) was deposited in the Herbarium of the Instituto de Biologia, Universidade Estadual de Campinas, Campinas-SP.
Extraction and isolation
Fresh petioles (86.0 g) of S. montevidensis ssp montevidensis were extracted with MeOH. After removal of the solvent by vacuum, the residue (32.0 g) was partitioned between EtOAc and H 2 O. The EtOAc (6.0 g) extract was subjected to column chromatography on a silica gel 60 to give n-hexane, n-hexane/EtOAc (95:5, 90:10, 80:20, 70:30, 60:40, 50:50) and MeOH fractions. These subfractions were named subfractions A, B, C, D, E, F, G and H, respectively. The fraction E eluted with n-hexane/ EtOAc 70:30 (602.0 mg) was further purified by column chromatography (CC) on silica gel 60 using an n-hexane-EtOAc gradient solvent system to obtain compounds 1 (12.0 mg) and 2 (40.0 mg).
3β-hydroxy-abieta -8,11,13-trien-7-one (2) 
Microorganisms used and growth condition
The fractions above were assayed against Gram-positive and Gramnegative bacteria by a broth microdilution assay to determine the minimal inhibitory concentrations (MICs) as described below. The assays were performed with Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 15442, Bacillus subtilis ATCC 6623, and Staphylococcus aureus ATCC 25923 obtained from the American Type Culture Collection (ATCC, Rockville, MD). For the antifungal assay, a single clinical isolate of each species (Candida albicans, C. krusei, C. parapsilosis, and C. tropicalis), obtained from vaginal mucosa, was selected for testing. The bacteria were maintained in Tryptic Soy Agar (Difco). The yeast was maintained in Sabouraud Dextrose Agar (Difco).
Antifungal susceptibility testing
The MICs of all the fractions and reference antifungal compounds were determined by microdilution techniques in RPMI 1640 (Sigma Chemical Co., St. Louis, MO) for yeast. 9 Inoculates were prepared in the same medium at a density adjusted to a 0.5 McFarland turbidity standard (10 6 colony-forming units [CFU] m/L) and diluted to a 1:10 ratio for the broth microdilution procedure. Microtiter trays were incubated at 37º C, and the MICs were recorded after 24 h of incubation. Two susceptibility endpoints were recorded for each isolate. The MIC was defined as the lowest concentration of compounds at which the tested microorganism does not demonstrate visible growth. Nystatin (Sigma Chemical Co., St. Louis, MO, USA) was included in the test as a control. When the MIC was equal or smaller than 100 µg/mL, the antimicrobial activity was considered significant. If the fractions displayed a MIC from 100 to 500 µg/mL, the antimicrobial activity was considered moderate; from 500 to 1000 µg/mL, the antimicrobial activity was considered weak; over 1000 µg/mL, the fractions were considered inactive. 10 
Antibacterial susceptibility testing
The MICs of all the extracts and reference antibiotics (tetracycline, vancomycin, and penicillin -Sigma Chemical Co., St. Louis, MO, US) were determined by microdilution techniques in Mueller-Hinton broth (Difco) according to CLSI. 9 Inoculates were prepared in the same medium at a density adjusted to a 0.5 McFarland turbidity standard (10 8 colony-forming units [CFU])/mL] and diluted 1:10 for the broth microdilution procedure. Microliter plates were incubated at 37 ºC and the MICs were recorded after 24 h of incubation. Two susceptibility endpoints were recorded for each isolate. The MIC was defined as the lowest concentration of compounds at which the tested microorganism did not demonstrate visible growth.
RESULT AND DISCUSSION
The results of the preliminary screening for antimicrobial activity of all fractions are summarized in Table 1 , which shows that six among ten fractions demonstrated significant activity against at least one of the microorganisms tested. However, the most active fraction was hexane/ EtOAc (70:30, fraction E) with an MIC = 31.2 µg/mL against C. krusei. Therefore, it was purified by sequential chromatographic techniques, with the metabolites 1 and 2 ( Figure 1) as the major constituents. Compound 2 was identified as 3β-hydroxy-abieta-8,11,13-trien-7-one by comparison of the IR, 1 H NMR, and 13 C NMR spectra with those already published. We now report the characterization of 1. correlations of H-16 (H-17) with H-14. This assumption was further confirmed by a NOE experiment, where correlation of H-14 with the H-7 was observed.
The NOESY and NOE experiments as well as coupling constants established the relative configuration of the compound 1. Proton H-3 (J 3ax,2eq =5.4 and J 3ax,2ax =10.8 Hz) had an α-disposition as showed by its coupling constants. It was further supported by NOESY correlations of H-3 with H-5 and H-3 with Me-19. No NOESY correlation was observed between H-7 and H-5 or H-7 and H-19, but the coupling constant corresponding to H-7 (bt, J = 3.0 Hz) and the 13 C NMR chemical shift values 11 suggests an α-disposition of the hydroxyl group at the C-7. These configurations ( Figure 2) were supported by an NOE spectrum that exhibited effects between H-3 (δ 3.35) with H-5 (δ 1.65) and H-1α (δ 1.56); H-7 (δ 4.85) with H-6β (δ 2.00) and H-14 (δ 7.19). Therefore, compound 1 was assigned to be 3β,7α -hydroxi-abieta-8,11,13-triene.
Finally, a literature survey revealed that abietane-type diterpenoids are recognized to inhibit Gram-positive bacteria and some fungi species with appreciable MIC values. 12 Therefore, compounds 1 and 2 may merit further experiments to evaluated their antimicrobial activities. 
